https://www.live-feeds.com/feed/glp-1-makers-novo-eli-lilly-sued-over-sudden-loss-of-vision-in-patientsContinuously updated, source-cited coverage. https://www.live-feeds.com/feed/glp-1-makers-novo-eli-lilly-sued-over-sudden-loss-of-vision-in-patientshttps://www.live-feeds.com/feed/glp-1-makers-novo-eli-lilly-sued-over-sudden-loss-of-vision-in-patients#u83213Fri, 25 Sep 2026 01:20:54 +0000Hundreds of patients have filed lawsuits against manufacturers of GLP-1 receptor agonists, including Ozempic, Wegovy, and Mounjaro, alleging the drugs cause a rare form of vision loss. Plaintiffs describe sudden blindness, which some sources characterize as an "eye stroke." The litigation targets companies like Novo Nordisk and Eli Lilly, claiming the medications increase the risk of this rare condition. While individual users have shared accounts of immediate sight loss, the legal actions seek to establish a direct link between the weight-loss and diabetes medications and these ocul